ZANNES MARIA (President, CEO) received a stock award from BIOAFFINITY TECHNOLOGIES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/2/2024ACC: 0001493152-24-026087
DirectorOfficer· President, CEO
Since Aug 2022
+33.78K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
33.78K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+33.78K
Price / share
—
Trade value
—
% of position
16.1%
7/1/2024
209.54K→243.32K
Total
Net shares
+33.78K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2024 | A · Award | +33.78K | — | — | 16.1% | 209.54K | 243.32K |
| Total | +33.78K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported